{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-073998","form_type":"8-K","ticker":"OVID","cik":"0001636651","company_name":"Ovid Therapeutics Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.362365+00:00","generated_at":"2026-06-01T04:07:16.624000+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ovid reports Takeda's Ph3 soticlestat misses primary endpoints; pipeline and cash runway update","bullets":["Takeda's Phase 3 SKYLINE in Dravet syndrome narrowly missed primary endpoint (p=0.06) but showed significant secondary endpoints (p≤0.008).","Takeda's Phase 3 SKYWAY in Lennox-Gastaut syndrome missed primary endpoint; safety profile consistent.","Ovid's cash runway expected into H1 2026; pipeline milestones include OV888 Phase 2 start H2 2024, OV329 data H2 2024, OV350 IND H2 2024.","Takeda will discuss data with regulators; Ovid will update guidance on potential milestones/royalties afterward."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-073998","json":"https://secwatch.observer/filing/0000950170-24-073998.json","markdown":"https://secwatch.observer/filing/0000950170-24-073998.md","text":"https://secwatch.observer/filing/0000950170-24-073998.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636651/000095017024073998/0000950170-24-073998-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636651/000095017024073998/ovid-20240617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:07:16.624000+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}